PROSTIN F2 ALPHA Drug Patent Profile
✉ Email this page to a colleague
When do Prostin F2 Alpha patents expire, and when can generic versions of Prostin F2 Alpha launch?
Prostin F2 Alpha is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROSTIN F2 ALPHA?
- What are the global sales for PROSTIN F2 ALPHA?
- What is Average Wholesale Price for PROSTIN F2 ALPHA?
Summary for PROSTIN F2 ALPHA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Clinical Trials: | 12 |
Patent Applications: | 444 |
DailyMed Link: | PROSTIN F2 ALPHA at DailyMed |
Recent Clinical Trials for PROSTIN F2 ALPHA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Medical Centre Maribor | Phase 4 |
Aswan University Hospital | N/A |
Yong Loo Lin School of Medicine | N/A |
US Patents and Regulatory Information for PROSTIN F2 ALPHA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROSTIN F2 ALPHA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROSTIN F2 ALPHA
See the table below for patents covering PROSTIN F2 ALPHA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
African Intellectual Property Organization (OAPI) | 3734 | ⤷ Sign Up | |
Sweden | 387340 | FORFARANDE FOR FRAMSTELLNING AV FRIFLYTANDE KRISTALLER AV TRIS-(HYDROZIMETYL)-AMINOMETANSALTET AV PGE?712 | ⤷ Sign Up |
Israel | 36860 | TRIS (HYDROXYMETHYL) AMINOMETHANE SALTS OF PGE2 AND PGF2ALPHA | ⤷ Sign Up |
South Africa | 7103181 | ⤷ Sign Up | |
Sweden | 339531 | ⤷ Sign Up | |
Netherlands | 7107062 | ⤷ Sign Up | |
Philippines | 9620 | MID-TERM ABORTION WITH PROSTAGLANDINS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |